Correspondence

Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening: non invasive prenatal testing

The NHS fetal anomaly screening programmes (FASP) position on non-invasive prenatal testing (NIPT).

From:
Public Health England
Published
1 January 2013

This publication was withdrawn on

This guidance has been withdrawn as it is out of date. Please refer to operational guidance to support the offer of NIPT.

Documents

[Withdrawn] Frequently asked questions: cell free fetal DNA (cffDNA) testing for Down’s, Edwards' and Patau's syndrome and other trisomies

PDF, 644 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Information on the current availability in the NHS of non-invasive prenatal screening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome.

It also includes information about the ongoing research testing whether the procedure is a viable option for NHS population screening.

Published 1 January 2013